Ototoxic hearing loss is hearing damage caused by medications, chemicals, or other substances that are toxic to the structures of the inner ear. It can range from mild, temporary ringing in the ears to severe, permanent hearing loss, depending on the substance involved, the dose, and individual risk factors. Hundreds of medications and industrial chemicals are known to be ototoxic, making this one of the more preventable forms of hearing loss when caught early.
How Ototoxic Substances Damage Your Hearing
Your inner ear contains tiny sensory cells called hair cells that convert sound vibrations into electrical signals your brain can interpret. These cells are irreplaceable in humans. Once they die, they don’t grow back. Ototoxic substances damage or destroy these hair cells, and many also harm the tissue that maintains the chemical balance of inner ear fluid, which hair cells need to function.
The damage typically starts in the base of the cochlea, where high-frequency sounds are processed. This is why the earliest signs of ototoxic hearing loss often involve difficulty hearing high-pitched sounds, like birds singing or a child’s voice, before lower frequencies are affected. Some substances also target the vestibular system, the part of your inner ear responsible for balance, causing dizziness, unsteady walking, and a visual disturbance called oscillopsia, where the world appears to bounce or blur during head movement.
Medications That Can Cause It
Several major drug classes carry ototoxic risk:
- Platinum-based chemotherapy drugs: Cisplatin is the most significant offender. In a large North American study of children, adolescents, and young adults treated with cisplatin, 44% developed moderate to severe hearing loss. The damage is typically permanent and worsens with higher cumulative doses.
- Aminoglycoside antibiotics: These are powerful antibiotics used for serious infections. They can damage both hearing and balance. The mechanism involves disruption of the energy-producing structures inside cells, which compromises the inner ear’s ability to maintain its delicate chemical environment.
- Loop diuretics: These are commonly prescribed for heart failure and fluid retention. They can cause hearing changes, though the effects are often reversible once the medication is adjusted.
- NSAIDs and aspirin: At high doses, common pain relievers like aspirin and ibuprofen can cause temporary hearing loss and tinnitus. The hearing changes typically resolve after the medication is reduced or stopped.
- Quinine: Used for malaria and sometimes leg cramps, quinine can cause temporary hearing changes and also appears to affect blood flow within the cochlea.
- Acetaminophen: Regular use at high doses has been linked to hearing changes, particularly in older adults.
Temporary vs. Permanent Damage
Not all ototoxic hearing loss is permanent. The outcome depends heavily on which substance caused it. Aspirin, NSAIDs, and quinine generally cause temporary hearing loss and tinnitus that resolve when you stop taking the medication or lower the dose. These drugs appear to alter how hair cells function without necessarily killing them.
Aminoglycoside antibiotics and cisplatin-based chemotherapy drugs are a different story. These substances destroy hair cells outright, and the resulting hearing loss is usually permanent. With cisplatin, the damage can also continue to worsen for months after treatment ends. Aminoglycoside damage sometimes appears suddenly, even after a single dose in genetically susceptible individuals.
Workplace Chemicals and Hearing
Medications aren’t the only ototoxic threat. According to the CDC’s National Institute for Occupational Safety and Health, several categories of industrial chemicals can damage hearing on their own or make noise-induced hearing loss worse.
Solvents like toluene, styrene, xylene, and trichloroethylene are common culprits, found in paints, adhesives, and manufacturing settings. Heavy metals including mercury compounds, lead, and organic tin compounds also carry ototoxic risk. Even asphyxiants like carbon monoxide, hydrogen cyanide, and tobacco smoke can contribute to hearing damage by starving the inner ear of oxygen. Workers exposed to both loud noise and these chemicals face a compounded risk that is greater than either hazard alone.
Genetic Risk Factors
Some people are dramatically more vulnerable to ototoxic hearing loss because of inherited genetic variations. The best-studied examples involve mutations in mitochondrial DNA, specifically in a gene called 12S rRNA. People who carry certain mutations at this gene have mitochondrial structures in their inner ear cells that more closely resemble bacterial structures, which is exactly what aminoglycoside antibiotics are designed to attack. This means a standard dose of an aminoglycoside antibiotic can cause sudden, profound hearing loss in these individuals.
Research has identified more than a dozen specific mutations linked to increased susceptibility, with some first discovered through families where multiple members developed hearing loss after antibiotic treatment. These mutations are inherited maternally, meaning they pass from mother to all children. Genetic testing before aminoglycoside treatment can identify people at highest risk, though it is not yet routine in most healthcare settings.
Early Warning Signs
Tinnitus, a ringing, buzzing, or hissing sound that no one else can hear, is typically the first symptom of ototoxic hearing loss. It can appear as soon as you start taking a medication or develop gradually over weeks to months. In some cases, symptoms don’t surface until up to five years after starting the drug.
Other early signs include difficulty understanding speech in noisy environments, needing to turn up the volume on devices, a feeling of fullness in the ears, or subtle balance problems like unsteadiness when walking in the dark. Because high-frequency hearing is affected first, you may not notice the loss in everyday conversation initially, since most speech falls in lower frequency ranges. By the time you notice difficulty with normal speech, significant damage may already be present.
How Ototoxic Hearing Loss Is Monitored
For patients receiving known ototoxic drugs like cisplatin or aminoglycosides, hearing monitoring should begin before the first dose. A comprehensive baseline hearing test includes standard frequency testing from 250 Hz to 8,000 Hz, extended high-frequency testing up to 16,000 or 20,000 Hz, and a quick objective test called otoacoustic emissions (OAE) that measures sounds produced by healthy hair cells. The OAE test takes less than a minute per ear, requires no active participation from the patient, and can detect damage to hair cells before it shows up on a standard hearing test.
Extended high-frequency testing is particularly valuable because ototoxic damage almost always appears at the highest frequencies first, then progresses downward. Catching a shift at 12,000 Hz gives clinicians a window to adjust treatment before the hearing loss reaches the frequencies that matter most for understanding speech. Monitoring continues throughout treatment and, for chemotherapy patients, for a period after treatment ends.
Prevention and Protection
The most important protective step is awareness. If you’re taking any medication on the ototoxic list, particularly at high doses or for extended periods, baseline and periodic hearing tests allow early detection before permanent damage accumulates. For some medications, switching to a less ototoxic alternative is possible once early changes are detected.
For children receiving cisplatin chemotherapy, a protective drug called sodium thiosulfate (brand name Pedmark) was approved by the FDA in September 2022. In clinical trials, this drug significantly reduced hearing loss rates. Among children with a type of liver cancer treated with cisplatin, 39% of those who also received sodium thiosulfate developed hearing loss, compared with 68% in the group receiving cisplatin alone. The drug is approved for pediatric patients one month and older with localized, non-metastatic solid tumors and is given intravenously after each cisplatin infusion.
For workers in industrial settings, reducing exposure to ototoxic chemicals through proper ventilation, protective equipment, and limiting simultaneous noise exposure are the primary strategies. Hearing conservation programs that account for chemical exposure, not just noise levels, provide the most effective protection.